Sage Therapeutics

Biotechnology

Sage Therapeutics develops treatments for brain disorders, with a focus on depression, epilepsy, and neurodegenerative diseases. The company's novel approach to modulating brain circuits through GABA receptors represents innovative neuroscience. Sage's approved treatment for postpartum depression addresses a historically neglected condition.